Health and Me

Rachel V Thomas

NATCO Pharma 1st To Launch Generic Semaglutide In India, Prices Start From Rs 1,290

With the patent on <span>semaglutide</span> expiring today in India, <span>NATCO Pharma</span> has become the first drugmaker to launch the generic version of the weight-loss drug in the country.

<span>NATCO</span> Pharma’s generic semaglutide injection prices start at INR 1,290 per month.

“NATCO is the first company to offer generic semaglutide in multi-dose vials with customized syringes… It is the most affordable GLP-1 currently in the Indian market as it is approximately 70 percent cheaper in cost than the pen device and 90 percent cheaper than the price of the innovator’s brand,” the Hyderabad-based company said, in a statement.

The company had received approval from the Central Drugs Standard Control Organization (CDSCO) in February 2026 to manufacture and market the drug, after a clinical comparison study.

Semaglutide works by targeting key areas of the brain involved in appetite regulation and food intake. It reduces hunger, improves satiety, and cuts down food cravings, eventually inducing weight loss.

It also improves insulin resistance and has a beneficial effect on the reduction of cardiometabolic events and risk factors. 

<h2>NATCO's <span rel="noindex">Semaglutide Drugs</span></h2>

NATCO's semaglutide drugs will be sold under brand names SEMANAT and SEMAFULL in multi-dose vial formats. It will be priced:

<ul><li>INR 1,290 per month for the 2 mg/1.5 ml and 4 mg/3 ml variants, </li><li>INR 1,750 for the 8 mg/3 ml dose.</li></ul>In addition, NATCO is also expected to launch its pen device in April. It will be priced at 

<ul><li>INR 4,000 for 2 mg/1.5ml, </li><li>INR 4,200 for 4 mg/3 ml, </li><li>INR 4,500 per month for 8 mg/3 ml.</li></ul> 

In comparison, <a href="https://www.healthandme.com/health-news/novo-nordisk-and-hims-hers-health-end-dispute-plan-to-sell-wegovy-together-article-153776417" data-type="tilCustomLink">Novo Nordisk</a>'s <span>Ozempic</span> and Wegovy in pen devices cost INR 8,800 and INR 10,850, respectively, per month for the starting doses.

NATCO has also signed a distribution partnership with <span>Eris</span> Lifesciences to co-market its therapy in India.

<h2>Other Generic Versions</h2>Separately, Eris has also announced its plans to launch a multi-dose vial under the brand name "Sundae". The company's generics will be at the same price for the type-2 diabetes indication. 

<span>Sun Pharmaceutical Industries</span>, Dr. Reddy’s Laboratories, and <span>Zydus Lifesciences</span> are also expected to introduce their versions of semaglutide on Saturday.

Others in the pipeline include Alkem Laboratories, Torrent Pharmaceuticals, and MSN Laboratories. 

With intense competition, analysts believe around 50 branded semaglutide generics will enter the Indian market within months, BBC reported.

Calling it a potential "magic-pill moment" for India, investment bank Jefferies predicted that the semaglutide market in the country could reach $1bn domestically.

<strong>Also read: </strong><a href="https://www.healthandme.com/health-news/cdsco-threatens-action-against-pharma-companies-for-promoting-glp-1-weight-loss-drugs-article-153818123" data-type="tilCustomLink">CDSCO threatens action against pharma companies for promoting GLP-1 weight-loss drugs</a> 

<h2>End Of <span rel="noindex">Novo Nordisk</span>’s Patents</h2>

In January this year, Canada became the first country to lose patent protection for semaglutide. However, the country's health regulator hasn’t approved any generics so far.

Novo Nordisk is expected to lose the patent in 10 more countries, including Brazil, China, South Africa, Turkey, and Canada, by the end of 2026.

In view of losing patent, Novo Nordisk recently cut prices for Wegovy in India. The company also launched its blockbuster brand Ozempic in December.

Health Conditions A-Z

health

natco

semaglutide

zydus lifesciences

semaglutide drugs

reddys laboratories

natco pharma

eris

sun pharmaceutical industries

ozempic

novo nordisk

Can Matcha Cause Infertility? Explains Expert

New AIIMS Study To Probe How PM2.5 Is Surging Lung Cancer Risk In India

Health News

8 Sit-Up Variations to Strengthen Your Core and Build Stability

Benefits Of Ayurvedic Health Supplement Ashwagandha

9 Anti-Inflammatory Breakfast Options You Should Try

5 Foods You Should Avoid For PCOS, Says Gynecologist

Love Sitting With Your Legs Crossed? Here’s You Should Avoid It

6 Daily Foods That Are Secretly Increasing Your Calories

9 Brain Boosters You Should Do Everyday

Hip Exercises That Will Keep You Flexible As You Age

9 Leg Exercises Office Workers’ Should Do At Home

Benefits of Having Herbal Tea Every Morning

9 Daily Habits That Boost Your Brain Power

Lower-Body Exercises That Are Game-Changers

How Drinking Apple Cider Vinegar Helps You

Aging Myths You Should Never Believe

Superfoods That Support Your Gut Health

What Happens To Your Body When You Eat Instant Noodles Every Day?

Health Issues Premature Babies Often Face

Exercises Office Workers Should Do For Their Heart Health

Reasons Why You Should Add Raw Turmeric To Your Diet

Benefits Of Drinking Milk At Night: Why You Should Do It

Food That Provides Vitamin B12 Naturally In Your Diet

Surprising Health Benefits Of Fenugreek Seeds

9 Superfoods You Should Eat For Your Brain Health

What Does Mental Health Support Look Like At Work?

Long Stretches You Should Do To Unwind From Your Day

Colon Cancer In Young Adults: Early Symptoms You Should Know

Health Benefits Of Eating Dry Fruits Everyday

Are You At Risk For Fried Rice Syndrome?

These Tests Reveal How Well You Are Aging

Lower-Back Exercises You Should Do After A Long-Day's Work

Children’s Diet – What Kids Need To Eat For Immunity Building

Common Diabetes Myths That Could Hurt Your Health

Love Spicy Food? Here’s How It Affects Your Health

Superfood List: Veggies And Fruits You Must Have For Immunity

Foods People With IBS Should Avoid

Exercises To Improve Digestion

Easy Work Lunches You Can Make In The Morning

Hunger Vs Craving: Difference Explained In 60 seconds

These Things Can Cause Your Heart To Age Faster

High Carb Foods That Are Actually Healthy

With the patent on semaglutide expiring today in India, NATCO Pharma has become the first drugmaker to launch the generic version of the weight-loss drug in the country. NATCO Pharma’s generic semaglutide injection prices start at INR 1,290 per month. “NATCO is the first company to offer generic semaglutide in multi-dose vials with customized syringes… It is the most affordable GLP-1 currently in the Indian market as it is approximately 70 percent cheaper in cost than the pen device and 90 percent cheaper than the price of the innovator’s brand,” the Hyderabad-based company said, in a statement. The company had received approval from the Central Drugs Standard Control Organization (CDSCO) in February 2026 to manufacture and market the drug, after a clinical comparison study.Semaglutide works by targeting key areas of the brain involved in appetite regulation and food intake. It reduces hunger, improves satiety, and cuts down food cravings, eventually inducing weight loss.It also improves insulin resistance and has a beneficial effect on the reduction of cardiometabolic events and risk factors.  NATCO's Semaglutide Drugs NATCO's semaglutide drugs will be sold under brand names SEMANAT and SEMAFULL in multi-dose vial formats. It will be priced:INR 1,290 per month for the 2 mg/1.5 ml and 4 mg/3 ml variants, INR 1,750 for the 8 mg/3 ml dose.In addition, NATCO is also expected to launch its pen device in April. It will be priced at INR 4,000 for 2 mg/1.5ml, INR 4,200 for 4 mg/3 ml, INR 4,500 per month for 8 mg/3 ml. In comparison, Novo Nordisk's Ozempic and Wegovy in pen devices cost INR 8,800 and INR 10,850, respectively, per month for the starting doses. NATCO has also signed a distribution partnership with Eris Lifesciences to co-market its therapy in India. Other Generic VersionsSeparately, Eris has also announced its plans to launch a multi-dose vial under the brand name "Sundae". The company's generics will be at the same price for the type-2 diabetes indication.  Sun Pharmaceutical Industries, Dr. Reddy’s Laboratories, and Zydus Lifesciences are also expected to introduce their versions of semaglutide on Saturday. Others in the pipeline include Alkem Laboratories, Torrent Pharmaceuticals, and MSN Laboratories.  With intense competition, analysts believe around 50 branded semaglutide generics will enter the Indian market within months, BBC reported. Calling it a potential "magic-pill moment" for India, investment bank Jefferies predicted that the semaglutide market in the country could reach $1bn domestically.Also read: CDSCO threatens action against pharma companies for promoting GLP-1 weight-loss drugs  End Of Novo Nordisk’s PatentsIn January this year, Canada became the first country to lose patent protection for semaglutide. However, the country's health regulator hasn’t approved any generics so far. Novo Nordisk is expected to lose the patent in 10 more countries, including Brazil, China, South Africa, Turkey, and Canada, by the end of 2026.In view of losing patent, Novo Nordisk recently cut prices for Wegovy in India. The company also launched its blockbuster brand Ozempic in December.

natco pharma’s 1st to launch generic semaglutide in india, prices start from rs 1,290

About Us

Contact Us

Terms & Conditions

Privacy Policy

Company

Health and Me is a premium website with content written and curated to function as a handbook for all Health concerns.

NATCO Pharma 1st To Launch Generic Semaglutide In India, Prices Start From Rs 1,290

New AIIMS Study To Probe How PM2.5 Is Surging Lung Cancer Risk In India

New National Dental Commission To Transform Dental Education In India

India Identifies 219 Districts As Priority For Intensified HIV/AIDS Interventions

Health Conditions A-Z